InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,284.00
(
0.36%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.31
(
0.99%
)
Bitcoin
61,425.78
(
1.03%
)
Post# of 252405
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119941
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Laloo77 post# 178220

Saturday, 05/24/2014 3:08:04 PM

Saturday, May 24, 2014 3:08:04 PM

Post# of 252405
PVCT, which has only four employees (according to Yahoo Finance), still sports a (fully-diluted) enterprise value of >$500M, although that’s down from $1B+ in Jan 2014 (#msg-96287931).

The company had a CC Friday afternoon to discuss the FDA’s denial of BTD for the company’s lead drug, PV-10:
http://finance.yahoo.com/news/provectus-biopharmaceuticals-inc-reaffirms-commitment-175300043.html

Earlier last week, PVCT issued to PR to “rebut” a Seeking Alpha piece claiming (among other things) that PV-10 would be denied BTD:
http://finance.yahoo.com/news/provectus-biopharmaceuticals-inc-refutes-inaccuracies-180800786.html

All told, PVCT looks like a great stock to avoid (unless you can short it).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up